Kalaris Therapeutics, Inc.
KLRS
$3.41
-$0.06-1.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.78% | -17.60% | 53.23% | -12.92% | -12.42% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 117.07% | 4.11% | -30.15% | -63.29% | 165.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 32.13% | -- | -- | -- | -- |
| Total Current Assets | -2.58% | -17.12% | 51.96% | -14.69% | -10.31% |
|
|
|||||
| Total Current Assets | -2.58% | -17.12% | 51.96% | -14.69% | -10.31% |
| Net Property, Plant & Equipment | -3.07% | -2.85% | -2.70% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.07% | 55.17% | -1.63% | 23.93% | 30.88% |
| Total Assets | -9.35% | -9.80% | 49.97% | -12.57% | -9.94% |
|
|
|||||
| Total Accounts Payable | 24.20% | -29.35% | 159.31% | -86.58% | 55.01% |
| Total Accrued Expenses | 5.98% | -15.52% | 56.25% | 30.82% | -12.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.46% | 0.32% | -15.96% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.16% | -16.83% | 60.16% | -20.73% | 7.13% |
|
|
|||||
| Total Current Liabilities | 8.16% | -16.83% | 60.16% | -20.73% | 7.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.66% | -3.45% | -3.17% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 1.50% | -3.90% | 9.19% | -1.05% | 1.30% |
|
|
|||||
| Common Stock & APIC | 0.27% | 0.27% | 24.47% | 0.33% | 0.31% |
| Retained Earnings | -6.74% | -6.79% | -6.67% | -8.61% | -8.95% |
| Treasury Stock & Other | -48.98% | -916.67% | 0.00% | -- | -- |
| Total Common Equity | -15.88% | -13.01% | 88.26% | -21.18% | -16.84% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.88% | -13.01% | 88.26% | -21.18% | -16.84% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.88% | -13.01% | 88.26% | -21.18% | -16.84% |
|
|
|||||